Skip to main content
. 2021 Feb 23;15(5):E234–E243. doi: 10.5489/cuaj.7252

Table 4.

Testosterone therapy monitoring schedule

Baseline 3 months 6 months Yearly
Symptom evaluation × × × ×
Adverse event monitoring × × ×
Serum testosterone × × × ×
Hematocrit × × ×
Prostate-specific antigen (PSA) × × × ×
Digital rectal examination (DRE) × ×